BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18291711)

  • 21. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Kwiatkowski DJ; Manning BD
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hamartin and tuberin: working together for tumour suppression.
    Jozwiak J
    Int J Cancer; 2006 Jan; 118(1):1-5. PubMed ID: 16206276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
    Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
    J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
    Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
    Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt regulates nuclear/cytoplasmic localization of tuberin.
    Rosner M; Freilinger A; Hengstschläger M
    Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
    Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
    Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cell cycle and tuberous sclerosis.
    Hengstschläger M; Rosner M
    Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment.
    de Vries PJ; Howe CJ
    Trends Mol Med; 2007 Aug; 13(8):319-26. PubMed ID: 17632034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B.
    Astrinidis A; Senapedis W; Coleman TR; Henske EP
    J Biol Chem; 2003 Dec; 278(51):51372-9. PubMed ID: 14551205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M; Freilinger A; Lubec G; Hengstschläger M
    Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition.
    Shiono M; Kobayashi T; Takahashi R; Sun G; Abe M; Zhang D; Wang L; Piao X; Takagi Y; Mineki R; Taka H; Tada N; Sonobe S; Momose S; Ueda M; Hino O
    Oncogene; 2008 Nov; 27(52):6690-7. PubMed ID: 18695678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus.
    York B; Lou D; Noonan DJ
    Mol Cancer Res; 2006 Nov; 4(11):885-97. PubMed ID: 17114346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tuberous sclerosis complex: balancing proliferation and survival.
    Tomasoni R; Mondino A
    Biochem Soc Trans; 2011 Apr; 39(2):466-71. PubMed ID: 21428921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
    Lugnier C; Majores M; Fassunke J; Pernhorst K; Niehusmann P; Simon M; Nellist M; Schoch S; Becker A
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1136-46. PubMed ID: 19918125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberin, p27 and mTOR in different cells.
    Burgstaller S; Rosner M; Lindengrün C; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Feb; 36(2):297-302. PubMed ID: 18386114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
    Nellist M; van Slegtenhorst MA; Goedbloed M; van den Ouweland AM; Halley DJ; van der Sluijs P
    J Biol Chem; 1999 Dec; 274(50):35647-52. PubMed ID: 10585443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal hamartin-binding and C-terminal GAP domain of tuberin can separate in vivo.
    Momose S; Kobayashi T; Tada N; Itoyama S; Hino O
    Biochem Biophys Res Commun; 2007 May; 356(3):693-8. PubMed ID: 17379185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.